124 related articles for article (PubMed ID: 2104939)
21. Modulation of immunologic responses in nontuberculous mycobacterial infections with indomethacin.
Mason UG; Kirkpatrick CH
J Clin Immunol; 1984 Mar; 4(2):112-7. PubMed ID: 6725531
[TBL] [Abstract][Full Text] [Related]
22. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
23. Changes in non-specific immune responses induced by repeated delayed-type hypersensitivity skin testing with multiple antigens.
Lesourd BM; Winters WD; Kniker WT
J Clin Lab Immunol; 1986 Apr; 19(4):187-92. PubMed ID: 3723589
[TBL] [Abstract][Full Text] [Related]
24. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell.
Wanebo HJ; Riley T; Katz D; Pace RC; Johns ME; Cantrell RW
Cancer; 1988 Feb; 61(3):462-74. PubMed ID: 2962730
[TBL] [Abstract][Full Text] [Related]
25. Effect of ranitidine on postoperative suppression of natural killer cell activity and delayed hypersensitivity.
Nielsen HJ; Pedersen BK; Moesgaard F; Haahr PM; Kehlet H
Acta Chir Scand; 1989 Aug; 155(8):377-82. PubMed ID: 2688344
[TBL] [Abstract][Full Text] [Related]
26. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
[TBL] [Abstract][Full Text] [Related]
27. Postoperative PMBC-derived IL-6 and TNF-alpha-release is uninfluenced by IL-12-mediated restoration of IFN-gamma synthesis.
Franke A; Lante W; Kurig E; Zoeller LG; Kollig E; Markewitz A
Scand Cardiovasc J; 2009 Apr; 43(2):136-44. PubMed ID: 19225954
[TBL] [Abstract][Full Text] [Related]
28. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer.
van Sandick JW; Gisbertz SS; ten Berge IJ; Boermeester MA; van der Pouw Kraan TC; Out TA; Obertop H; van Lanschot JJ
Ann Surg; 2003 Jan; 237(1):35-43. PubMed ID: 12496528
[TBL] [Abstract][Full Text] [Related]
29. [Predictive factors of postoperative infection. Value of cutaneous immunologic tests].
Farron A; Tschantz P
Helv Chir Acta; 1991 May; 57(6):909-11. PubMed ID: 1889993
[TBL] [Abstract][Full Text] [Related]
30. An imbalance in T-helper cell subsets alters immune response after cardiac surgery.
Markewitz A; Faist E; Lang S; Hültner L; Weinhold C; Reichart B
Eur J Cardiothorac Surg; 1996; 10(1):61-7. PubMed ID: 8776187
[TBL] [Abstract][Full Text] [Related]
31. Delayed hypersensitivity testing for the prediction of postoperative complications.
Ausobsky JR; Bean P; Proctor J; Pollock AV
Br J Surg; 1982 Jun; 69(6):346-8. PubMed ID: 7082963
[TBL] [Abstract][Full Text] [Related]
32. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
[TBL] [Abstract][Full Text] [Related]
33. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection.
Lyons A; Kelly JL; Rodrick ML; Mannick JA; Lederer JA
Ann Surg; 1997 Oct; 226(4):450-8; discussion 458-60. PubMed ID: 9351713
[TBL] [Abstract][Full Text] [Related]
34. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
Herzog WR; Ferreri NR; Ptak W; Askenase PW
J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
[TBL] [Abstract][Full Text] [Related]
35. Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors.
Quattrocchi KB; Miller CH; Wagner FC; DeNardo SJ; DeNardo GL; Ovodov K; Frank EH
J Neurosurg; 1992 Nov; 77(5):694-9. PubMed ID: 1403109
[TBL] [Abstract][Full Text] [Related]
36. Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens.
Wiebke EA; Rosenberg SA; Lotze MT
J Clin Oncol; 1988 Sep; 6(9):1440-9. PubMed ID: 3262151
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
Powrie F; Menon S; Coffman RL
Eur J Immunol; 1993 Sep; 23(9):2223-9. PubMed ID: 8370402
[TBL] [Abstract][Full Text] [Related]
38. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis.
Kitching AR; Tipping PG; Kurimoto M; Holdsworth SR
J Immunol; 2000 Oct; 165(8):4649-57. PubMed ID: 11035108
[TBL] [Abstract][Full Text] [Related]
39. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
40. Immune response: effects of operative stress in a pediatric model.
Mendoza-Sagaon M; Gitzelmann CA; Herreman-Suquet K; Pegoli W; Talamini MA; Paidas CN
J Pediatr Surg; 1998 Feb; 33(2):388-93. PubMed ID: 9498424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
